Oh dear,
OCC's surprise buy rating on Kochie's "The Call" seems to have been a bad omen. Whilst we wait for another tardy announcement on the long overdue ATI vs Surgery trial results, other untrialled stem cells methods in the musculoskeletal field gain attention in the media:
https://www.surfer.com/trending-news/surfer-shane-dorian-stem-cell
(ex pro-surfer Dorian following a number of MMA fighters over the border to Mexico for stem cell treatment on ailing joints and limbs)
It is nearly ten years since I had successful stem cell treatment via OCC that I remain grateful for, but that ATI is not TGA approved yet and in market helping more Australians is sad for patients, the company and shareholders. Remplir and Striate are at least in market earning revenues I suppose, you wouldn't know it from the share price. We only hope the ATI results are late because they are being prepared for J&J in particular.
Media thread, page-336
-
- There are more pages in this discussion • 293 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
-0.015(3.23%) |
Mkt cap ! $94.30M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 47.0¢ | 44.8¢ | $101.0K | 221.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6739 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 9799 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| OCC (ASX) Chart |